HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of specific amino acid sequence (QRRAA) of HLA-DRB1*0405 with rheumatoid arthritis in a Tunisian population.

Abstract
This study aimed to investigate HLA-DRB1 alleles in rheumatoid arthritis (RA) patients from Tunisia and to examine the effect of these alleles on disease severity. HLA-DRBI alleles and sub-typing of DRBI*04 and *01 were determined in 90 patients and 100 healthy controls, by PCR-SSP. HLA-DRB1*04 was significantly higher in patients (51.1%) than in controls (27%) [OR=2.83, p=0.00066]. DRBJ*0405 was found to be the unique DR4 allele associated with RA (28.88% vs 6%) [OR=6.36, p=0.000059]. A significant decrease in the frequency of HLA-DRB1*0701 was observed in RA patients (16.66%) compared to controls (36%) [p=0.0026]. However, the frequency of patients carrying the shared epitope (SE) QRRAA, was slightly increased compared with controls (37.8% vs 23%) [OR=2.03, p=0.039]. We found that the presence of rheumatoid factor, HLA-DR4 and HLA-DRBI*0405 were not significantly associated with bone erosions or the presence of extra-joint involvement. In our population, the SE (QRRAA) expressed in DRBI*04 alleles is related to the susceptibility to RA but it is not involved in RA severity in Tunisia, while DRBI*0701 might protect against this disease.
AuthorsT Dhaouadi, I Sfar, L Abdelmoula, R Bardi, S Jendoubi-Ayed, M Makhlouf, H Aouadi, T Ben Abdallah, R Zouari, K Ayed, Y Lakhoua-Gorgi
JournalArchives de l'Institut Pasteur de Tunis (Arch Inst Pasteur Tunis) Vol. 87 Issue 1-2 Pg. 53-9 ( 2010) ISSN: 0020-2509 [Print] Tunisia
PMID21598828 (Publication Type: Journal Article)
Chemical References
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • HLA-DRB1*04:05 antigen
Topics
  • Adult
  • Alleles
  • Amino Acid Sequence
  • Arthritis, Rheumatoid (genetics)
  • Female
  • HLA-DR Antigens (genetics)
  • HLA-DRB1 Chains
  • Humans
  • Male
  • Tunisia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: